Skip to main content
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5584
-0.0370 (-6.21%)
At close: Nov 13, 2026, 4:00 PM EST
0.5600
+0.0016 (0.29%)
After-hours: Nov 13, 2026, 7:59 PM EST

Humacyte Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.42.04--1.571.26
Revenue Growth
52.51%---23.91%-15.29%
Gross Profit
-25.39-76.37-88.6-76.55-61.7-60.08
Operating Income
-109.59-107.44-114.4-96.94-84.58-81.21
Net Income
-94.7-40.83-148.7-110.78-11.97-26.48
Earnings Per Share
-0.42-0.26-1.26-1.07-0.12-0.66
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
64.5250.544.9480.45151.88225.5
Total Debt
66.4865.3581.6858.0550.6751.18
Net Cash (Debt)
-1.96-14.85-36.7422.4101.21174.32
Net Cash Growth
----77.87%-41.94%1475.03%
Net Cash Per Share
-0.01-0.09-0.310.220.984.36

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-88.26-105.04-98.12-73.31-71.13-81.19
Capital Expenditures
-0.32-0.88-1.57-2.28-1.05-0.22
Free Cash Flow
-88.58-105.93-99.69-75.59-72.18-81.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-4573.71%-5271.69%---5404.35%-6429.77%
Pretax Margin
-3955.05%-2003.58%---764.54%-2096.36%
Profit Margin
-3952.25%-2003.58%---764.54%-2096.36%
FCF Margin
-3697.04%-5197.55%---4611.95%-6445.76%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
64.7490.96--139.03591.27